Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NEO-212 by Neonc Technologies for Metastatic Brain Tumor: Likelihood of Approval
NEO-212 is under clinical development by Neonc Technologies and currently in Phase II for Metastatic Brain Tumor. According to GlobalData,...
NEO-212 by Neonc Technologies for Glioblastoma Multiforme (GBM): Likelihood of Approval
NEO-212 is under clinical development by Neonc Technologies and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData,...
NEO-212 by Neonc Technologies for Astrocytoma: Likelihood of Approval
NEO-212 is under clinical development by Neonc Technologies and currently in Phase II for Astrocytoma. According to GlobalData, Phase II...